Q4 2024 Holdings
Filed 2025-02-14 | 73 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $341.6K | 55,189 | 0.0% |
| Traws Pharma Inc(TRAW) | COM NEW | 68232V884 | $666.0K | 75,000 | 0.0% |
| MacroGenics Inc(MGNX) | COM | 556099109 | $910.0K | 280,000 | 0.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $1.1M | 45,000 | 0.1% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $1.7M | 125,000 | 0.1% |
| Achilles Therapeutics PLC(698) | SPONSORED ADS | 00449L102 | $1.7M | 1,500,000 | 0.1% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $1.8M | 80,000 | 0.1% |
| Bausch Health Cos Inc(BHC) | COM | 071734107 | $2.0M | 250,000 | 0.1% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $2.5M | 370,000 | 0.1% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $2.7M | 185,000 | 0.2% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $2.9M | 425,000 | 0.2% |
| TransMedics Group Inc(TMDX) | COM | 89377M109 | $3.1M | 50,000 | 0.2% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $3.2M | 1,500,000 | 0.2% |
| Passage Bio Inc | COM | 702712100 | $3.5M | 6,100,000 | 0.2% |
| Verve Therapeutics Inc | COM | 92539P101 | $3.6M | 645,000 | 0.2% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $3.9M | 915,000 | 0.2% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $4.1M | 2,465,000 | 0.2% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $4.4M | 2,000,000 | 0.3% |
| Sutro Biopharma Inc | COM | 869367102 | $4.7M | 2,570,000 | 0.3% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $4.9M | 1,400,000 | 0.3% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $5.0M | 180,000 | 0.3% |
| OnKure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $5.5M | 635,000 | 0.3% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $6.1M | 525,000 | 0.4% |
| iTeos Therapeutics Inc(5E7) | COM | 46565G104 | $6.9M | 900,000 | 0.4% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $7.0M | 1,230,000 | 0.4% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $7.7M | 305,000 | 0.5% |
| Zai Lab Ltd(ZLAB) | ADR | 98887Q104 | $7.9M | 300,000 | 0.5% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $7.9M | 1,200,000 | 0.5% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $9.1M | 485,000 | 0.5% |
| Perrigo Co PLC(PRGO) | SHS | G97822103 | $9.6M | 375,000 | 0.6% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $9.8M | 11,500,000 | 0.6% |
| Agilent Technologies Inc(A) | COM | 00846U101 | $10.1M | 75,000 | 0.6% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $11.4M | 2,850,000 | 0.7% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $12.0M | 5,600,000 | 0.7% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $12.4M | 710,000 | 0.7% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $13.8M | 990,000 | 0.8% |
| Establishment Labs Holdings In(ESTA) | COM | G31249108 | $13.8M | 300,000 | 0.8% |
| Regeneron Pharmaceuticals Inc(REGN) | COM | 75886F107 | $14.2M | 20,000 | 0.8% |
| Roivant Sciences Ltd(ROIV) | SHS | G76279101 | $14.8M | 1,250,000 | 0.9% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $15.5M | 475,000 | 0.9% |
| UroGen Pharma Ltd(URGN) | COM | M96088105 | $17.4M | 1,630,000 | 1.0% |
| Day One Biopharmaceuticals Inc(DAWN) | COM | 23954D109 | $18.2M | 1,440,000 | 1.1% |
| Liquidia Corp(LQDA) | COM NEW | 53635D202 | $20.7M | 1,760,000 | 1.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $20.8M | 595,000 | 1.2% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $23.0M | 495,000 | 1.4% |
| Nyxoah SA(NYXH) | SHS | B6S7WD106 | $23.4M | 2,924,216 | 1.4% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $23.4M | 1,075,000 | 1.4% |
| Globus Medical Inc(GMED) | CL A | 379577208 | $26.9M | 325,000 | 1.6% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $29.3M | 95,000 | 1.7% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $30.4M | 250,000 | 1.8% |